Solasonine is primarily investigated for its potential anticancer properties. It has shown cytotoxic effects against various cancer cell lines, including liver, breast, and colon cancers, by inducing apoptosis and inhibiting cell proliferation. Research also suggests it may interfere with tumor growth and metastasis through modulation of signaling pathways such as PI3K/AKT and MAPK. In addition to its anticancer activity, solasonine exhibits antimicrobial and antifungal effects, making it a candidate for development in infectious disease treatments. It is also used as a precursor in the semi-synthesis of steroidal drugs, leveraging its structural similarity to steroid hormones. Despite its potential, solasonine's toxicity and low bioavailability remain challenges for therapeutic use.